Molecular regulation of telomerase activity in aging

Protein and Cell

Volumn 2, Issue 9, 2011, Pages 726-738

  Nicholls, Craig ^a,c   Li, He ^a   Wang, Jian Qiu ^b   Liu, Jun Ping ^a,b,c,d  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b HANGZHOU NORMAL UNIVERSITY   (China)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

aging; telomerase; telomerase reverse transcriptase (TERT)

Indexed keywords

ANDROGEN; AZACITIDINE; CELL PROTEIN; DNA; DYSKERIN; ESTROGEN; GROWTH HORMONE; HEAT SHOCK PROTEIN 90; HISTONE; MESSENGER RNA; MZ 5 156; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN P23; PROTEIN P53; PROTEIN POT1; PROTEIN TPP1; SEX HORMONE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE REVERSE TRANSCRIPTASE ALPHA+ BETA-; TELOMERASE REVERSE TRANSCRIPTASE ALPHA-BETA+; TELOMERASE REVERSE TRANSCRIPTASE ALPHA-BETA-; TELOMERIC REPEAT BINDING FACTOR 1; TESTOSTERONE; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR ETS 2; TRANSCRIPTION FACTOR SP1; TRICHOSTATIN A; UNCLASSIFIED DRUG;

AGING; ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANDROGEN THERAPY; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE ARREST; CELL DEATH; CELL IMMORTALIZATION; CELL STRESS; CELL SURVIVAL; CRYSTAL STRUCTURE; DEACYLATION; DNA DAMAGE; DNA REPLICATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; ENZYME STRUCTURE; EPIGENETICS; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; GENE; GENE DELETION; GENE REPRESSION; GENE STRUCTURE; GENOMIC INSTABILITY; HORMONAL REGULATION; HTERT GENE; HUMAN; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; LONGEVITY; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NEOPLASM; NONHUMAN; ONCOGENE C MYC; OVARY CANCER; PREMATURE AGING; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; RNA TRANSLATION; TELOMERASE RNA COMPONENT; TELOMERE; TERATOCARCINOMA; TRANSCRIPTION REGULATION;

EID: 80955135601     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-011-1093-3     Document Type: Review

References (144)

1. Akalin, A., Elmore, L. W., Forsythe, H. L., Amaker, B. A., McCollum, E. D., Nelson, P. S., Ware, J. L., and Holt, S. E. (2001). A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression. Cancer Res 61, 4791-4796.
2. Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., and Harley, C. B. (1992). Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 89, 10114-10118.
3. Armanios, M. (2009). Syndromes of Telomere Shortening. Annu Rev Genomics Hum Genet 10, 45-61.
4. Armbruster, B. N., Banik, S. S., Guo, C., Smith, A. C., and Counter, C. M. (2001). N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo. Mol Cell Biol 21, 7775-7786.
5. Atzmon, G., Cho, M., Cawthon, R. M., Budagov, T., Katz, M., Yang, X., Siegel, G., Bergman, A., Huffman, D. M., Schechter, C. B., et al. (2010). Evolution in health and medicine Sackler colloquium: Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc Natl Acad Sci U S A 107, 1710-1717.
6. Autexier, C., Pruzan, R., Funk, W. D., and Greider, C. W. (1996). Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA. EMBO J 15, 5928-5935.
7. Ayouaz, A., Raynaud, C., Heride, C., Revaud, D., and Sabatier, L. (2008). Telomeres: hallmarks of radiosensitivity. Biochimie 90, 60-72.
8. Bachand, F., and Autexier, C. (2001). Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions. Mol Cell Biol 21, 1888-1897.
9. Bagheri, S., Nosrati, M., Li, S., Fong, S., Torabian, S., Rangel, J., Moore, D. H., Federman, S., Laposa, R. R., Baehner, F. L., et al. (2006). Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci U S A 103, 11306-11311.
10. Banik, S. S., Guo, C., Smith, A. C., Margolis, S. S., Richardson, D. A., Tirado, C. A., and Counter, C. M. (2002). C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity. Mol Cell Biol 22, 6234-6246.
11. Banks, W. A., Morley, J. E., Farr, S. A., Price, T. O., Ercal, N., Vidaurre, I., and Schally, A. V. (2010). Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice. Proc Natl Acad Sci U S A 107, 22272-22277.
12. Bayne, S., Jones, M. E., Li, H., Pinto, A. R., Simpson, E. R., and Liu, J. P. (2008). Estrogen deficiency leads to telomerase inhibition, telomere shortening and reduced cell proliferation in the adrenal gland of mice. Cell Res 18, 1141-1150.
13. Bayne, S., Li, H., Jones, M. E., Pinto, A. R., van Sinderen, M., Drummond, A., Simpson, E. R., and Liu, J. P. (2011). Estrogen deficiency reversibly induces telomere shortening in mouse granulosa cells and ovarian aging in vivo. Protein Cell 2, 333-346.
14. Britt, K. L., Drummond, A. E., Dyson, M., Wreford, N. G., Jones, M. E., Simpson, E. R., and Findlay, J. K. (2001). The ovarian phenotype of the aromatase knockout (ArKO) mouse. J Steroid Biochem Mol Biol 79, 181-185.
15. Britt, K. L., Kerr, J., O'Donnell, L., Jones, M. E., Drummond, A. E., Davis, S. R., Simpson, E. R., and Findlay, J. K. (2002). Estrogen regulates development of the somatic cell phenotype in the eutherian ovary. FASEB J 16, 1389-1397.
16. Browner, W. S., Kahn, A. J., Ziv, E., Reiner, A. P., Oshima, J., Cawthon, R. M., Hsueh, W. C., and Cummings, S. R. (2004). The genetics of human longevity. Am J Med 117, 851-860.
17. Bryan, T. M., Goodrich, K. J., and Cech, T. R. (2000). Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase. Mol Cell 6, 493-499.
18. Calado, R. T., and Young, N. S. (2009). Telomere diseases. N Engl J Med 361, 2353-2365.
19. Cassar, L., Li, H., Pinto, A. R., Nicholls, C., Bayne, S., and Liu, J. P. (2008). Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. Cancer Res 68, 9157-9166.
20. Cha, Y., Kwon, S. J., Seol, W., and Park, K. S. (2008). Estrogen receptor-alpha mediates the effects of estradiol on telomerase activity in human mesenchymal stem cells. Mol Cells 26, 454-458.
21. Chai, W., Ford, L. P., Lenertz, L., Wright, W. E., and Shay, J. W. (2002). Human Ku70/80 associates physically with telomerase through interaction with hTERT. J Biol Chem 277, 47242-47247.
22. Chang, J. T., Lu, Y. C., Chen, Y. J., Tseng, C. P., Chen, Y. L., Fang, C. W., and Cheng, A. J. (2006). hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells. Br J Cancer 94, 870-878.
23. Chen, J. L., Blasco, M. A., and Greider, C. W. (2000). Secondary structure of vertebrate telomerase RNA. Cell 100, 503-514.
24. Cohen, S. B., Graham, M. E., Lovrecz, G. O., Bache, N., Robinson, P. J., and Reddel, R. R. (2007). Protein composition of catalytically active human telomerase from immortal cells. Science 315, 1850-1853.
25. Colgin, L. M., Wilkinson, C., Englezou, A., Kilian, A., Robinson, M. O., and Reddel, R. R. (2000). The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2, 426-432.
26. Collins, K. (2006). The biogenesis and regulation of telomerase holoenzymes. Nat Rev Mol Cell Biol 7, 484-494.
27. Cong, Y. S., Wen, J., and Bacchetti, S. (1999). The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 8, 137-142.
28. Counter, C. M., Meyerson, M., Eaton, E. N., Ellisen, L. W., Caddle, S. D., Haber, D. A., and Weinberg, R. A. (1998). Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16, 1217-1222.
29. Cuthbert, A. P., Bond, J., Trott, D. A., Gill, S., Broni, J., Marriott, A., Khoudoli, G., Parkinson, E. K., Cooper, C. S., and Newbold, R. F. (1999). Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst 91, 37-45.
30. Dallaire, F., Dupuis, S., Fiset, S., and Chabot, B. (2000). Heterogeneous nuclear ribonucleoprotein A1 and UP1 protect mammalian telomeric repeats and modulate telomere replication in vitro. J Biol Chem 275, 14509-14516.
31. Dang, C. V. (1999). c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19, 1-11.
32. de Lange, T. (2009). How telomeres solve the end-protection problem. Science 326, 948-952.
33. Denchi, E. L. (2009). Give me a break: how telomeres suppress the DNA damage response. DNA Repair (Amst) 8, 1118-1126.
34. Dessain, S. K., Yu, H., Reddel, R. R., Beijersbergen, R. L., and Weinberg, R. A. (2000). Methylation of the human telomerase gene CpG island. Cancer Res 60, 537-541.
35. Devereux, T. R., Horikawa, I., Anna, C. H., Annab, L. A., Afshari, C. A., and Barrett, J. C. (1999). DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res 59, 6087-6090.
36. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995). The RNA component of human telomerase. Science 269, 1236-1241.
37. Fiset, S., and Chabot, B. (2001). hnRNP A1 may interact simultaneously with telomeric DNA and the human telomerase RNA in vitro. Nucleic Acids Res 29, 2268-2275.
38. Fisher, C. R., Graves, K. H., Parlow, A. F., and Simpson, E. R. (1998). Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A 95, 6965-6970.
39. Forsythe, H. L., Jarvis, J. L., Turner, J. W., Elmore, L. W., and Holt, S. E. (2001). Stable association of hsp90 and p23, but Not hsp70, with active human telomerase. J Biol Chem 276, 15571-15574.
40. Friedman, K. L., and Cech, T. R. (1999). Essential functions of aminoterminal domains in the yeast telomerase catalytic subunit revealed by selection for viable mutants. Genes Dev 13, 2863-2874.
41. Geserick, C., Tejera, A., González-Suárez, E., Klatt, P., and Blasco, M. A. (2006). Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-beta signaling. Oncogene 25, 4310-4319.
42. Gillis, A. J., Schuller, A. P., and Skordalakes, E. (2008). Structure of the Tribolium castaneum telomerase catalytic subunit TERT. Nature 455, 633-637.
43. González-Suárez, E., Geserick, C., Flores, J. M., and Blasco, M. A. (2005). Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 24, 2256-2270.
44. González-Suárez, E., Samper, E., Ramírez, A., Flores, J. M., Martín-Caballero, J., Jorcano, J. L., and Blasco, M. A. (2001). Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 20, 2619-2630.
45. Grasselli, A., Nanni, S., Colussi, C., Aiello, A., Benvenuti, V., Ragone, G., Moretti, F., Sacchi, A., Bacchetti, S., Gaetano, C., et al. (2008). Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ Res 103, 34-42.
46. Greenberg, R. A., O'Hagan, R. C., Deng, H., Xiao, Q., Hann, S. R., Adams, R. R., Lichtsteiner, S., Chin, L., Morin, G. B., and DePinho, R. A. (1999). Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18, 1219-1226.
47. Greider, C. W., and Blackburn, E. H. (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413.
48. Greider, C. W., and Blackburn, E. H. (1987). The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51, 887-898.
49. Günes, C., Lichtsteiner, S., Vasserot, A. P., and Englert, C. (2000). Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res 60, 2116-2121.
50. Guo, C., Armbruster, B. N., Price, D. T., and Counter, C. M. (2003). In vivo regulation of hTERT expression and telomerase activity by androgen. J Urol 170, 615-618.
51. Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H., Meyerson, M., and Weinberg, R. A. (1999). Inhibition of telomerase limits the growth of human cancer cells. Nat Med 5, 1164-1170.
52. Harley, C. B. (1991). Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256, 271-282.
53. Harley, C. B. (2008). Telomerase and cancer therapeutics. Nat Rev Cancer 8, 167-179.
54. Heiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., and Dokal, I. (1998). X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 19, 32-38.
55. Herbert, B., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., and Corey, D. R. (1999). Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci U S A 96, 14276-14281.
56. Herrera, E., Samper, E., and Blasco, M. A. (1999). Telomere shortening in mTR-/-embryos is associated with failure to close the neural tube. EMBO J 18, 1172-1181.
57. Holt, S. E., Aisner, D. L., Baur, J., Tesmer, V. M., Dy, M., Ouellette, M., Trager, J. B., Morin, G. B., Toft, D. O., Shay, J. W., et al. (1999). Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 13, 817-826.
58. Horikawa, I., Cable, P. L., Afshari, C., and Barrett, J. C. (1999). Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59, 826-830.
59. Horikawa, I., Oshimura, M., and Barrett, J. C. (1998). Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinog 22, 65-72.
60. Huard, S., Moriarty, T. J., and Autexier, C. (2003). The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity. Nucleic Acids Res 31, 4059-4070.
61. Jacobs, S. A., Podell, E. R., and Cech, T. R. (2006). Crystal structure of the essential N-terminal domain of telomerase reverse transcriptase. Nat Struct Mol Biol 13, 218-225.
62. Jaskelioff, M., Muller, F. L., Paik, J. H., Thomas, E., Jiang, S., Adams, A. C., Sahin, E., Kost-Alimova, M., Protopopov, A., Cadiñanos, J., et al. (2011). Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469, 102-106.
63. Kalantaridou, S. N., Naka, K. K., Bechlioulis, A., Makrigiannakis, A., Michalis, L., and Chrousos, G. P. (2006). Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement. Trends Endocrinol Metab 17, 101-109.
64. Kang, S. S., Kwon, T., Kwon, D. Y., and Do, S. I. (1999). Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 274, 13085-13090.
65. Kelleher, C., Teixeira, M. T., Förstemann, K., and Lingner, J. (2002). Telomerase: biochemical considerations for enzyme and substrate. Trends Biochem Sci 27, 572-579.
66. Kiaris, H., and Schally, A. V. (1999). Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone. Proc Natl Acad Sci U S A 96, 226-231.
67. Kimura, A., Ohmichi, M., Kawagoe, J., Kyo, S., Mabuchi, S., Takahashi, T., Ohshima, C., Arimoto-Ishida, E., Nishio, Y., Inoue, M., et al. (2004). Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 23, 4505-4515.
68. Kimura, M., Barbieri, M., Gardner, J. P., Skurnick, J., Cao, X., van Riel, N., Rizzo, M. R., Paoliso, G., and Aviv, A. (2007). Leukocytes of exceptionally old persons display ultra-short telomeres. Am J Physiol Regul Integr Comp Physiol 293, R2210-R2217.
69. Kimura, M., Cherkas, L. F., Kato, B. S., Demissie, S., Hjelmborg, J. B., Brimacombe, M., Cupples, A., Hunkin, J. L., Gardner, J. P., Lu, X., et al. (2008). Offspring's leukocyte telomere length, paternal age, and telomere elongation in sperm. PLoS Genet 4, e37.
70. Kugoh, H., Shigenami, K., Funaki, K., Barrett, J. C., and Oshimura, M. (2003). Human chromosome 5 carries a putative telomerase repressor gene. Genes Chromosomes Cancer 36, 37-47.
71. Kyo, S., Takakura, M., Kanaya, T., Zhuo, W., Fujimoto, K., Nishio, Y., Orimo, A., and Inoue, M. (1999). Estrogen activates telomerase. Cancer Res 59, 5917-5921.
72. Kyo, S., Takakura, M., Taira, T., Kanaya, T., Itoh, H., Yutsudo, M., Ariga, H., and Inoue, M. (2000). Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 28, 669-677.
73. LaBranche, H., Dupuis, S., Ben-David, Y., Bani, M. R., Wellinger, R. J., and Chabot, B. (1998). Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Genet 19, 199-202.
74. Lai, C. K., Mitchell, J. R., and Collins, K. (2001). RNA binding domain of telomerase reverse transcriptase. Mol Cell Biol 21, 990-1000.
75. Laviolette, L. A., Garson, K., Macdonald, E. A., Senterman, M. K., Courville, K., Crane, C. A., and Vanderhyden, B. C. (2010). 17betaestradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer. Endocrinology 151, 929-938.
76. Lee, H. W., Blasco, M. A., Gottlieb, G. J., Horner, J. W. 2nd, Greider, C. W., and DePinho, R. A. (1998). Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574.
77. Li, H., Pinto, A. R., Duan, W., Li, J., Toh, B. H., and Liu, J. P. (2005). Telomerase down-regulation does not mediate PC12 pheochromocytoma cell differentiation induced by NGF, but requires MAP kinase signalling. J Neurochem 95, 891-901.
78. Li, H., Zhao, L., Yang, Z., Funder, J. W., and Liu, J. P. (1998). Telomerase is controlled by protein kinase Calpha in human breast cancer cells. J Biol Chem 273, 33436-33442.
79. Lin, J., Kroenke, C. H., Epel, E., Kenna, H. A., Wolkowitz, O. M., Blackburn, E., and Rasgon, N. L. (2011). Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline. Brain Res 1379, 224-231.
80. Ling, S., Zhou, L., Li, H., Dai, A., Liu, J. P., Komesaroff, P. A., and Sudhir, K. (2006). Effects of 17beta-estradiol on growth and apoptosis in human vascular endothelial cells: influence of mechanical strain and tumor necrosis factor-alpha. Steroids 71, 799-808.
81. Liu, J. P., Chen, S. M., Cong, Y. S., Nicholls, C., Zhou, S. F., Tao, Z. Z., and Li, H. (2010). Regulation of telomerase activity by apparently opposing elements. Ageing Res Rev 9, 245-256.
82. Loayza, D., and De Lange, T. (2003). POT1 as a terminal transducer of TRF1 telomere length control. Nature 423, 1013-1018.
83. Lopatina, N. G., Poole, J. C., Saldanha, S. N., Hansen, N. J., Key, J. S., Pita, M. A., Andrews, L. G., and Tollefsbol, T. O. (2003). Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. Biochem Biophys Res Commun 306, 650-659.
84. Martínez, P., Thanasoula, M., Muñoz, P., Liao, C., Tejera, A., McNees, C., Flores, J. M., Fernández-Capetillo, O., Tarsounas, M., and Blasco, M. A. (2009). Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev 23, 2060-2075.
85. McNees, C. J., Tejera, A. M., Martínez, P., Murga, M., Mulero, F., Fernandez-Capetillo, O., and Blasco, M. A. (2010). ATR suppresses telomere fragility and recombination but is dispensable for elongation of short telomeres by telomerase. J Cell Biol 188, 639-652.
86. Meeker, A. K., Sommerfeld, H. J., and Coffey, D. S. (1996). Telomerase is activated in the prostate and seminal vesicles of the castrated rat. Endocrinology 137, 5743-5746.
87. Misiti, S., Nanni, S., Fontemaggi, G., Cong, Y. S., Wen, J., Hirte, H. W., Piaggio, G., Sacchi, A., Pontecorvi, A., Bacchetti, S., et al. (2000). Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol Cell Biol 20, 3764-3771.
88. Mitchell, M., Gillis, A., Futahashi, M., Fujiwara, H., and Skordalakes, E. (2010). Structural basis for telomerase catalytic subunit TERT binding to RNA template and telomeric DNA. Nat Struct Mol Biol 17, 513-518.
89. Moehren, U., Papaioannou, M., Reeb, C. A., Grasselli, A., Nanni, S., Asim, M., Roell, D., Prade, I., Farsetti, A., and Baniahmad, A. (2008). Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development. FASEB J 22, 1258-1267.
90. Murnane, J. P. (2010). Telomere loss as a mechanism for chromosome instability in human cancer. Cancer Res 70, 4255-4259.
91. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
92. Nesbit, C. E., Tersak, J. M., and Prochownik, E. V. (1999). MYC oncogenes and human neoplastic disease. Oncogene 18, 3004-3016.
93. Njajou, O. T., Cawthon, R. M., Damcott, C. M., Wu, S. H., Ott, S., Garant, M. J., Blackburn, E. H., Mitchell, B. D., Shuldiner, A. R., and Hsueh, W. C. (2007). Telomere length is paternally inherited and is associated with parental lifespan. Proc Natl Acad Sci U S A 104, 12135-12139.
94. Njajou, O. T., Hsueh, W. C., Blackburn, E. H., Newman, A. B., Wu, S. H., Li, R., Simonsick, E. M., Harris, T. M., Cummings, S. R., and Cawthon, R. M., and the Health ABC study. (2009). Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a populationbased cohort study. J Gerontol A Biol Sci Med Sci 64, 860-864.
95. Oh, S., Song, Y. H., Yim, J., and Kim, T. K. (2000). Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 19, 1485-1490.
96. Oh, W., Ghim, J., Lee, E. W., Yang, M. R., Kim, E. T., Ahn, J. H., and Song, J. (2009). PML-IV functions as a negative regulator of telomerase by interacting with TERT. J Cell Sci 122, 2613-2622.
97. Ornish, D., Lin, J., Daubenmier, J., Weidner, G., Epel, E., Kemp, C., Magbanua, M. J., Marlin, R., Yglecias, L., Carroll, P. R., et al. (2008). Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol 9, 1048-1057.
98. Park, J. I., Venteicher, A. S., Hong, J. Y., Choi, J., Jun, S., Shkreli, M., Chang, W., Meng, Z., Cheung, P., Ji, H., et al. (2009). Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460, 66-72.
99. Peng, Y., Mian, I. S., and Lue, N. F. (2001). Analysis of telomerase processivity: mechanistic similarity to HIV-1 reverse transcriptase and role in telomere maintenance. Mol Cell 7, 1201-1211.
100. Pinto, A. R., Li, H., Nicholls, C., and Liu, J. P. (2011). Telomere protein complexes and interactions with telomerase in telomere maintenance. Front Biosci 16, 187-207.
101. Ramírez, R., Carracedo, J., Jiménez, R., Canela, A., Herrera, E., Aljama, P., and Blasco, M. A. (2003). Massive telomere loss is an early event of DNA damage-induced apoptosis. J Biol Chem 278, 836-842.
102. Ravindranath, N., Ioffe, S. L., Marshall, G. R., Ramaswamy, S., Plant, T. M., and Dym, M. (2001). Androgen depletion activates telomerase in the prostate of the nonhuman primate, Macaca mulatta. Prostate 49, 79-89.
103. Rochette, P. J., and Brash, D. E. (2010). Human telomeres are hypersensitive to UV-induced DNA Damage and refractory to repair. PLoS Genet 6, e1000926.
104. Rudolph, K. L., Chang, S., Lee, H. W., Blasco, M., Gottlieb, G. J., Greider, C., and DePinho, R. A. (1999). Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712.
105. Seimiya, H., Sawada, H., Muramatsu, Y., Shimizu, M., Ohko, K., Yamane, K., and Tsuruo, T. (2000). Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J 19, 2652-2661.
106. Seth, A., and Watson, D. K. (2005). ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41, 2462-2478.
107. Sfeir, A., Kosiyatrakul, S. T., Hockemeyer, D., MacRae, S. L., Karlseder, J., Schildkraut, C. L., and de Lange, T. (2009). Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138, 90-103.
108. Sharma, H. W., Sokoloski, J. A., Perez, J. R., Maltese, J. Y., Sartorelli, A. C., Stein, C. A., Nichols, G., Khaled, Z., Telang, N. T., and Narayanan, R. (1995). Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci U S A 92, 12343-12346.
109. Shay, J. W., and Bacchetti, S. (1997). A survey of telomerase activity in human cancer. Eur J Cancer 33, 787-791.
110. Smith, L. L., Coller, H. A., and Roberts, J. M. (2003). Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5, 474-479.
111. Soda, H., Raymond, E., Sharma, S., Lawrence, R., Davidson, K., Oka, M., Kohno, S., Izbicka, E., and Von Hoff, D. D. (2000). Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro. Prostate 43, 161-168.
112. Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., et al. (2002). Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci U S A 99, 12606-12611.
113. Takakura, M., Kyo, S., Kanaya, T., Hirano, H., Takeda, J., Yutsudo, M., and Inoue, M. (1999). Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59, 551-557.
114. Takakura, M., Kyo, S., Sowa, Y., Wang, Z., Yatabe, N., Maida, Y., Tanaka, M., and Inoue, M. (2001). Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res 29, 3006-3011.
115. Tang, L., and Sawers, R. S. (1989). Twin pregnancy in premature ovarian failure after estrogen treatment: a case report. Am J Obstet Gynecol 161, 172-173.
116. Teixeira, M. T., Arneric, M., Sperisen, P., and Lingner, J. (2004). Telomere length homeostasis is achieved via a switch between telomerase-extendible and -nonextendible states. Cell 117, 323-335.
117. Terry, D. F., Nolan, V. G., Andersen, S. L., Perls, T. T., and Cawthon, R. (2008). Association of longer telomeres with better health in centenarians. J Gerontol A Biol Sci Med Sci 63, 809-812.
118. Theimer, C. A., and Feigon, J. (2006). Structure and function of telomerase RNA. Curr Opin Struct Biol 16, 307-318.
119. Ting, N. S., Pohorelic, B., Yu, Y., Lees-Miller, S. P., and Beattie, T. L. (2009). The human telomerase RNA component, hTR, activates the DNA-dependent protein kinase to phosphorylate heterogeneous nuclear ribonucleoprotein A1. Nucleic Acids Res 37, 6105-6115.
120. Ting, N. S., Yu, Y., Pohorelic, B., Lees-Miller, S. P., and Beattie, T. L. (2005). Human Ku70/80 interacts directly with hTR, the RNA component of human telomerase. Nucleic Acids Res 33, 2090-2098.
121. Tomás-Loba, A., Flores, I., Fernández-Marcos, P. J., Cayuela, M. L., Maraver, A., Tejera, A., Borrás, C., Matheu, A., Klatt, P., Flores, J. M., et al. (2008). Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell 135, 609-622.
122. Toogun, O. A., Dezwaan, D. C., and Freeman, B. C. (2008). The hsp90 molecular chaperone modulates multiple telomerase activities. Mol Cell Biol 28, 457-467.
123. Toogun, O. A., Zeiger, W., and Freeman, B. C. (2007). The p23 molecular chaperone promotes functional telomerase complexes through DNA dissociation. Proc Natl Acad Sci U S A 104, 5765-5770.
124. Ulaner, G. A., Hu, J. F., Vu, T. H., Giudice, L. C., and Hoffman, A. R. (1998). Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58, 4168-4172.
125. Ulaner, G. A., Hu, J. F., Vu, T. H., Giudice, L. C., and Hoffman, A. R. (2001). Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 91, 644-649.
126. Verdun, R. E., and Karlseder, J. (2006). The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 127, 709-720.
127. Wang, J., Xie, L. Y., Allan, S., Beach, D., and Hannon, G. J. (1998). Myc activates telomerase. Genes Dev 12, 1769-1774.
128. Wang, S., and Zhu, J. (2004). The hTERT gene is embedded in a nuclease-resistant chromatin domain. J Biol Chem 279, 55401-55410.
129. Won, J., Yim, J., and Kim, T. K. (2002a). Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells. FASEB J 16, 1943-1945.
130. Won, J., Yim, J., and Kim, T. K. (2002b). Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J Biol Chem 277, 38230-38238.
131. Wong, J. M., and Collins, K. (2003). Telomere maintenance and disease. Lancet 362, 983-988.
132. Wu, K. J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., and Dalla-Favera, R. (1999). Direct activation of TERT transcription by c-MYC. Nat Genet 21, 220-224.
133. Wymenga, L. F., Wisman, G. B., Veenstra, R., Ruiters, M. H., and Mensink, H. J. (2000). Telomerase activity in needle biopsies from prostate cancer and benign prostates. Eur J Clin Invest 30, 330-335.
134. Xia, J., Peng, Y., Mian, I. S., and Lue, N. F. (2000). Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase. Mol Cell Biol 20, 5196-5207.
135. Xin, H., Liu, D., Wan, M., Safari, A., Kim, H., Sun, W., O'Connor, M. S., and Songyang, Z. (2007). TPP1 is a homologue of ciliate TEBPbeta and interacts with POT1 to recruit telomerase. Nature 445, 559-562.
136. Xu, D., Dwyer, J., Li, H., Duan, W., and Liu, J. P. (2008). Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. J Biol Chem 283, 23567-23580.
137. Xu, D., Popov, N., Hou, M., Wang, Q., Björkholm, M., Gruber, A., Menkel, A. R., and Henriksson, M. (2001). Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci U S A 98, 3826-3831.
138. Yi, X., Shay, J. W., and Wright, W. E. (2001). Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 29, 4818-4825.
139. Yu, C. C., Lo, S. C., and Wang, T. C. (2001). Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells. Biochem J 355, 459-464.
140. Zaug, A. J., Podell, E. R., Nandakumar, J., and Cech, T. R. (2010). Functional interaction between telomere protein TPP1 and telomerase. Genes Dev 24, 613-622.
141. Zhang, Q. S., Manche, L., Xu, R. M., and Krainer, A. R. (2006). hnRNP A1 associates with telomere ends and stimulates telomerase activity. RNA 12, 1116-1128.
142. Zhang, W., Kapusta, L. R., Slingerland, J. M., and Klotz, L. H. (1998). Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res 58, 619-621.
143. Zhang, X., Mar, V., Zhou, W., Harrington, L., and Robinson, M. O. (1999). Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 13, 2388-2399.
144. Zinn, R. L., Pruitt, K., Eguchi, S., Baylin, S. B., and Herman, J. G. (2007). hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67, 194-201.